Scarica l'app Stockscreener
2.31
2.67%
0.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SAVA Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$2.25
Aprire:
$2.24
Volume 24 ore:
632.96K
Relative Volume:
0.72
Capitalizzazione di mercato:
$111.59M
Reddito:
-
Utile/perdita netta:
$-97.22M
Rapporto P/E:
-1.6739
EPS:
-1.38
Flusso di cassa netto:
$-82.44M
1 W Prestazione:
+7.94%
1M Prestazione:
-1.70%
6M Prestazione:
-11.15%
1 anno Prestazione:
-91.98%
Intervallo 1D:
$2.2216
$2.3384
Intervallo di 1 settimana:
$2.105
$2.3384
Portata 52W:
$1.15
$33.98
Cassava Sciences Inc Stock (SAVA) Company Profile
Nome
Cassava Sciences Inc
Settore
Industria
Telefono
512-501-2444
Indirizzo
6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX
Confronta SAVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SAVA
Cassava Sciences Inc
|
2.31 | 108.69M | 0 | -97.22M | -82.44M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-10-08 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-07-01 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-11-16 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-07-15 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
| 2021-04-27 | Iniziato | B. Riley Securities | Buy |
| 2021-02-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-10-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-09-23 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2020-05-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2020-05-15 | Downgrade | Maxim Group | Buy → Hold |
| 2020-01-10 | Reiterato | Maxim Group | Buy |
Mostra tutto
Cassava Sciences Inc Borsa (SAVA) Ultime notizie
Using Python tools to backtest Cassava Sciences Inc. Equity Warrant strategies2025 Investor Takeaways & Smart Money Movement Tracker - Newser
What to expect from Cassava Sciences Inc. Equity Warrant in the next 30 daysJuly 2025 Sector Moves & Low Volatility Stock Recommendations - Newser
Will breakout in Cassava Sciences Inc. lead to full recovery2025 Technical Overview & Advanced Technical Analysis Signals - Newser
Will Cassava Sciences Inc. benefit from macro trends2025 Support & Resistance & Fast Gain Swing Alerts - Newser
Detecting support and resistance levels for Cassava Sciences Inc. Equity WarrantTrade Signal Summary & Expert Approved Momentum Ideas - Newser
Tick level data insight on Cassava Sciences Inc. volatilityQuarterly Risk Review & Daily Risk Controlled Trade Plans - Newser
Analyzing drawdowns of Cassava Sciences Inc. with statistical toolsSwing Trade & Weekly Watchlist for Hot Stocks - Newser
Using Ichimoku Cloud for Cassava Sciences Inc. technicals2025 Market WrapUp & Accurate Trade Setup Notifications - Newser
Tools to assess Cassava Sciences Inc.’s risk profileEarnings Trend Report & Reliable Entry Point Trade Alerts - Newser
Cassava Sciences Inc. Equity Warrant recovery potential after sell offQuarterly Risk Review & Expert Verified Movement Alerts - Newser
What moving averages say about Cassava Sciences Inc.Weekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Building trade automation scripts for Cassava Sciences Inc. Equity WarrantProduct Launch & Technical Buy Zone Confirmation - Newser
Will Cassava Sciences Inc. Equity Warrant price bounce be sustainableSell Signal & High Return Stock Watch Alerts - Newser
How to read the order book for Cassava Sciences Inc. Equity WarrantTrend Reversal & Smart Allocation Stock Tips - Newser
Will Breakout in Cassava Sciences Inc. Equity Warrant Sustain Through Next Week getLinesFromResByArray error: size == 0 - 더경남뉴스
Using AI based signals to follow Cassava Sciences Inc. Equity WarrantTake Profit & Daily Profit Focused Stock Screening - Newser
Price momentum metrics for Cassava Sciences Inc. explainedQuarterly Profit Review & Community Driven Trade Alerts - Newser
Published on: 2025-08-27 14:17:41 - Newser
What institutional flow reveals about Cassava Sciences Inc. Equity WarrantPortfolio Risk Summary & Free Growth Oriented Trading Recommendations - Newser
Long term hold vs stop loss in Cassava Sciences Inc.2025 AllTime Highs & Accurate Trade Setup Notifications - Newser
Using AI based signals to follow Cassava Sciences Inc.Quarterly Investment Review & Advanced Technical Signal Analysis - Newser
Will Cassava Sciences Inc. price bounce be sustainableJuly 2025 Update & Fast Gain Stock Trading Tips - Newser
What’s the recovery path for long term holders of Cassava Sciences Inc. Equity WarrantJuly 2025 Technicals & Fast Moving Stock Watchlists - Newser
Custom strategy builders for tracking Cassava Sciences Inc.2025 Big Picture & Scalable Portfolio Growth Methods - Newser
How moving averages guide Cassava Sciences Inc. tradingPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
What recovery options are there for Cassava Sciences Inc. Equity Warrant2025 Short Interest & Real-Time Volume Triggers - Newser
Lead Plaintiff Appointed in Cassava Sciences Class Action — Here’s How You Can Recover Your Losses - TradingView
What machine learning models say about Cassava Sciences Inc.2025 Key Highlights & Technical Pattern Alert System - Newser
Cassava Sciences Inc. stock trendline breakdownOil Prices & Community Supported Trade Ideas - Newser
Using Bollinger Bands to evaluate Cassava Sciences Inc. Equity WarrantJuly 2025 Pullbacks & Safe Entry Point Identification - Newser
Trend Dashboard Flags Cassava Sciences Inc. Equity Warrant As Potential Swing TradeTrade Entry Report & AI Forecasted Entry and Exit Points - beatles.ru
Can Cassava Sciences Inc. Equity Warrant rally from current levelsPortfolio Value Summary & Weekly Chart Analysis and Trade Guides - Newser
Why Cassava Sciences Inc. Equity Warrant stock attracts strong analyst attention getLinesFromResByArray error: size == 0 - 더경남뉴스
Published on: 2025-08-26 22:05:54 - Newser
Using flow based indicators on Cassava Sciences Inc.July 2025 Technicals & Stepwise Entry/Exit Trade Alerts - Newser
Chart based analysis of Cassava Sciences Inc. trendsIndex Update & AI Enhanced Trading Alerts - Newser
How to integrate Cassava Sciences Inc. into portfolio analysis tools2025 Valuation Update & Safe Capital Growth Tips - Newser
What’s next for Cassava Sciences Inc. Equity Warrant stock priceGDP Growth & Weekly Chart Analysis and Guides - Newser
Cassava Sciences Inc. Equity Warrant stock trend forecastGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Exit strategy if you’re trapped in Cassava Sciences Inc. Equity WarrantJuly 2025 Pullbacks & Free Growth Oriented Trading Recommendations - Newser
Can Cassava Sciences Inc. recover in the next quarterWeekly Stock Recap & Accurate Buy Signal Alerts - Newser
Custom watchlist performance reports with Cassava Sciences Inc.Market Growth Report & Fast Momentum Entry Tips - Newser
Real time breakdown of Cassava Sciences Inc. Equity Warrant stock performanceJuly 2025 Summary & Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-26 09:35:38 - Newser
Cassava Sciences Inc Azioni (SAVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cassava Sciences Inc Azioni (SAVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Option Exercise |
1.18 |
50,000 |
59,000 |
71,300 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.86 |
59,800 |
230,828 |
11,500 |
| Schoen Eric | Chief Financial Officer |
Nov 29 '24 |
Sale |
3.82 |
2,000 |
7,640 |
0 |
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):